Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9212051rdf:typepubmed:Citationlld:pubmed
pubmed-article:9212051lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C0015295lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C1413767lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C1456379lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C0013879lld:lifeskim
pubmed-article:9212051lifeskim:mentionsumls-concept:C2350180lld:lifeskim
pubmed-article:9212051pubmed:issue8lld:pubmed
pubmed-article:9212051pubmed:dateCreated1997-9-2lld:pubmed
pubmed-article:9212051pubmed:abstractTextTwo hormone-responsive segments, one in the region of the promoter and one in intron 1, are identified in two homologous androgen-regulated and differentially expressed rat genes encoding the cystatin-related proteins (CRPs). Footprint analysis with the androgen receptor (AR) DNA-binding domain on the promoter-containing fragments reveals an AR-binding site downstream of the transcription start point in the crp2 gene (ARBSd/crp2, +40/+63). It displays an androgen response element-like sequence motif 5'-AGAAGAaaaTGTACA-3' and overlaps with the ATG translation start codon. A double-stranded oligonucleotide containing this sequence forms a DNA-protein complex with the full-length AR synthesized by vaccinia, as seen in band shift assays. Additional AR-binding sites, ARBSu/crp1 and ARBSu/crp2, occur 5' upstream of the transcription start point and are located at an identical position (-142/ -120) in crp1 and crp2. The AR affinity for these two slightly different sequence motifs is relatively weak. The biological function of all three AR-binding sites as transcription control elements has been studied. The ARBSd/crp2 element clearly shows androgen-response element characteristics. The contribution of the common upstream element to the androgen-dependent control of reporter gene transcription is less clear. The transcription of a reporter gene construct containing the crp2 footprint fragment crp2F (-273/+88) is hormonally regulated as determined by transfection into the human breast cancer cell line T-47D. Androgens, but also glucocorticoids, efficiently stimulate steroid-dependent transcription of the chloramphenicol acetyltransferase gene. Mutation of the 5'-TGTACA-3' sequence in ARBSd/crp2 destroys the AR binding and abolishes the androgen-dependent synthesis of chloramphenicol acetyltransferase. A large fragment derived from intron 1 of the crp1 and crp2 gene can also provide the androgen-dependent transcription of chimeric constructs in T-47D cells. However, the induction measured is less than the one observed with crp2F (-273/+88), and this activity seems to reside in several subfragments that each display a low but consistent androgen responsiveness.lld:pubmed
pubmed-article:9212051pubmed:languageenglld:pubmed
pubmed-article:9212051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:citationSubsetIMlld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9212051pubmed:statusMEDLINElld:pubmed
pubmed-article:9212051pubmed:monthJullld:pubmed
pubmed-article:9212051pubmed:issn0888-8809lld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:HeynsWWlld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:PeetersBBlld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:RombautsWWlld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:AldyDDlld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:DevosAAlld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:WinderickxJJlld:pubmed
pubmed-article:9212051pubmed:authorpubmed-author:ClaessensFFlld:pubmed
pubmed-article:9212051pubmed:issnTypePrintlld:pubmed
pubmed-article:9212051pubmed:volume11lld:pubmed
pubmed-article:9212051pubmed:ownerNLMlld:pubmed
pubmed-article:9212051pubmed:authorsCompleteYlld:pubmed
pubmed-article:9212051pubmed:pagination1033-43lld:pubmed
pubmed-article:9212051pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:meshHeadingpubmed-meshheading:9212051-...lld:pubmed
pubmed-article:9212051pubmed:year1997lld:pubmed
pubmed-article:9212051pubmed:articleTitleIdentification of a functional androgen-response element in the exon 1-coding sequence of the cystatin-related protein gene crp2.lld:pubmed
pubmed-article:9212051pubmed:affiliationDivision of Biochemistry, Faculty of Medicine, University of Leuven, Belgium.lld:pubmed
pubmed-article:9212051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9212051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9212051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9212051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9212051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9212051lld:pubmed